Ikanekt Research And Development Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 10.00 K
as on 10-12-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 1120.34%
(FY 2022)
- Ebitda 1467.20%
(FY 2022)
- Net Worth 799.36%
(FY 2022)
- Total Assets 314.38%
(FY 2022)
About Ikanekt Research And Development
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Srirang Ramamoorthy and Suchithra Sreedhar serve as directors at the Company.
- CIN/LLPIN
U73100TZ2018PTC031143
- Company No.
031143
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ikanekt Research And Development?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srirang Ramamoorthy  | Director | 23-Oct-2018 | Current |
| Suchithra Sreedhar | Director | 23-Oct-2018 | Current |
Financial Performance of Ikanekt Research And Development.
Ikanekt Research And Development Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1120.34% increase in profit. The company's net worth Soared by an impressive increase of 799.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ikanekt Research And Development?
Unlock access to Ikanekt Research And Development's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Ikanekt Biomedical Technologies Private LimitedActive 1 year 10 months
Srirang Ramamoorthy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ikanekt Research And Development?
Unlock and access historical data on people associated with Ikanekt Research And Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ikanekt Research And Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikanekt Research And Development's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
